Gain Therapeutics, Inc. — 10-Q Filings
15 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Gain Therapeutics, Inc. (GANX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Gain Therapeutics, Inc. has filed 15 10-Q documents with the SEC since 2020. To view all SEC filings by Gain Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001104659-25-110347 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001558370-25-011220 | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001558370-25-007747 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001558370-24-015709 | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001558370-24-011589 | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001558370-24-008132 | May 14, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0001558370-23-019014 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001558370-23-014499 | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001558370-23-009510 | May 12, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001558370-22-017414 | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001558370-22-012533 | Aug 8, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001558370-22-008968 | May 16, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001558370-21-015636 | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001558370-21-011445 | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001558370-21-006665 | May 10, 2021 | Mar 31, 2021 |